Mapping the cancer vaccine landscape.

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Analysis reveals growth in cancer vaccine trials, primarily targeting therapeutic applications.

The research shows that cancer vaccine development is rapidly advancing, especially in therapeutic vaccines.
Two predominant cancer types are targeted: non-small-cell lung cancer at 12% and melanoma at 11%.
Analyzed data from over 2100 clinical trials revealed an explosive growth since 2008, suggesting increased research activity.
Most trials (45%) are occurring in the USA, with a notable focus on adult populations, comprising 94% of participants.

Hu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark